Highland Capital Management (Tennessee)’s Regeneron Pharmaceuticals REGN Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-928	Closed	-$415K	–	379
2017 Q3	$415K	Buy	+928	New	+$442K	0.03%	283
2017 Q2	–	Sell	-1,304	Closed	-$505K	–	378
2017 Q1	$505K	Sell	1,304 -323	-20%	-$120K	0.04%	253
2016 Q4	$597K	Sell	1,627 -502	-24%	-$191K	0.05%	247
2016 Q3	$856K	Buy	+2,129	New	+$854K	0.07%	238
2015 Q4	–	Sell	-100	Closed	-$47K	–	495
2015 Q3	$47K	Hold	100	–	–	﹤0.01%	380
2015 Q2	$51K	Buy	+100	New	+$48.8K	﹤0.01%	383

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Highland Capital Management (Tennessee)'s REGN Position: Q4 2017 in Review

Highland Capital Management (Tennessee) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 928 shares — an estimated $415K sold.

Highland Capital Management (Tennessee) first reported a position in REGN in Q2 2015 and held it in 6 quarters. The position peaked at $856K in Q3 2016. 639 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

Highland Capital Management (Tennessee) reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Highland Capital Management (Tennessee) sold 928 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $415K.
Highland Capital Management (Tennessee) first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 6 quarters.
Highland Capital Management (Tennessee)'s Regeneron Pharmaceuticals position peaked at $856K in Q3 2016.
639 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2017, filed 26 Jan 2018.